Cargando…

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

This study aims at investigating the relationship between cyclooxygenase-2 expression in tumour vs stroma inflammatory compartment and its possible clinical role. The study included 99 stage IB-IV cervical cancer patients: immunostaining of tumour tissue sections was performed with rabbit antiserum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrandina, G, Lauriola, L, Zannoni, G F, Distefano, M G, Legge, F, Salutari, V, Gessi, M, Maggiano, N, Scambia, G, Ranelletti, F O
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376190/ https://www.ncbi.nlm.nih.gov/pubmed/12402155 http://dx.doi.org/10.1038/sj.bjc.6600578

Ejemplares similares

Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters
por: Ferrandina, G, et al.
Publicado: (2005)

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ
por: Boland, G P, et al.
Publicado: (2004)

Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2006)

Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival
por: Spizzo, G, et al.
Publicado: (2003)

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
por: Stessels, F, et al.
Publicado: (2004)

Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis
por: Maaser, K, et al.
Publicado: (2003)

c-erbB-2 is not a major factor in the development of colorectal cancer
por: McKay, J A, et al.
Publicado: (2002)

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells
por: Valabrega, G, et al.
Publicado: (2003)

Defects in death-inducing signalling complex formation prevent JNK activation and Fas-mediated apoptosis in DU 145 prostate carcinoma cells
por: Curtin, J F, et al.
Publicado: (2003)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

HPV infection and number of lifetime sexual partners are strong predictors for ‘natural’ regression of CIN 2 and 3
por: Chan, J K, et al.
Publicado: (2003)

Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling
por: Renaudin, K, et al.
Publicado: (2004)

The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients
por: de Manzoni, G, et al.
Publicado: (2002)

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells
por: Journe, F, et al.
Publicado: (2004)

Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
por: Zidar, Nina, et al.
Publicado: (2009)

Cytology vs molecular analysis for the detection of head and neck squamous cell carcinoma in oesopharyngeal brush samples: a prospective study in 56 patients
por: Temam, S, et al.
Publicado: (2003)

Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003)

Prognostic value of Goseki histological classification in adenocarcinoma of the cardia
por: Fontana, M G, et al.
Publicado: (2003)

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer
por: Sagara, Y, et al.
Publicado: (2004)

Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
por: Rocca, G La, et al.
Publicado: (2004)

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status
por: Müller, H M, et al.
Publicado: (2003)

Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues
por: de Nigris, F, et al.
Publicado: (2002)

ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
por: Vicent, S, et al.
Publicado: (2004)

Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells
por: Siavash, H, et al.
Publicado: (2004)

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
por: Hoskin, P J, et al.
Publicado: (2003)

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients
por: Itoi, T, et al.
Publicado: (2004)

Cellular responses to ErbB-2 overexpression in human mammary luminal epithelial cells: comparison of mRNA and protein expression
por: White, S L, et al.
Publicado: (2004)

The prognostic influence of bcl-2 in malignant glioma
por: McDonald, F E, et al.
Publicado: (2002)

Binding of TGF-β1 latency-associated peptide (LAP) to αvβ6 integrin modulates behaviour of squamous carcinoma cells
por: Thomas, G J, et al.
Publicado: (2002)

Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells
por: Huang, G C, et al.
Publicado: (2002)

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003)

Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections
por: Bekkers, R L M, et al.
Publicado: (2003)

Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer
por: Hardt, P D, et al.
Publicado: (2004)

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma
por: Passalidou, E, et al.
Publicado: (2003)

Impaired ΔNp63 expression associates with reduced β-catenin and aggressive phenotypes of urothelial neoplasms
por: Koga, F, et al.
Publicado: (2003)

An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue
por: Abe, N, et al.
Publicado: (2003)

Survivin expression in oral squamous cell carcinoma
por: Muzio, L Lo, et al.
Publicado: (2003)

KOC is a novel molecular indicator of malignancy
por: Mueller, F, et al.
Publicado: (2003)

Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management
por: Sapino, A, et al.
Publicado: (2003)

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage
por: Pardo, F S, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_d5lienbecf64j730cb89f6grrq